MIP-1 alpha (NCI)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMIP-1 alpha (NCI)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMacrophage inflammatory protein 1-α stimulants
TargetsMacrophage inflammatory protein 1-α
Therapy Area/IndicationsRetroviridae InfectionsAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsRetroviridae InfectionsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksN/A